A carregar...
BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy
PURPOSE: Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplasia with a broad spectrum of clinical manifestations and outcomes in children. The somatic BRAF(V600E) mutation occurs frequently, but clinical significance remains to be determined. PATIENTS AND METHODS: BRAF(V600E) mutat...
Na minha lista:
Publicado no: | J Clin Oncol |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
American Society of Clinical Oncology
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5321082/ https://ncbi.nlm.nih.gov/pubmed/27382093 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.65.9508 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|